NTRB Stock Discussion

Nutriband Inc. Description

The Company is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Its lead product under development is its abuse deterrent fentanyl transdermal system which the Company is developing to provide clinicians and patients with an abuse deterrent transdermal fentanyl product for use in managing chronic pain requiring opioid therapy. The product is combined with properties designed to help combat the opioid crisis by deterring the abuse and misuse of fentanyl patches

Sector: Healthcare
Industry: Biotechnology
Keywords: Euphoriants Opioids Chronic Pain Analgesics Heroin Morphine Fentanyl Anilides Semisynthetic Opioids